BioCentury
ARTICLE | Clinical News

Lidakol: Began a 10-patient Phase II study of Lidakol in AIDS patients with KS.

January 22, 1996 8:00 AM UTC

LIDAK Pharmaceuticals (LDAKA), La Jolla, Calif. Product: Lidakol, n-docosanol 10 percent topical cream Indication: Kaposi's sarcoma in AIDS Status: Began a 10-patient Phase II study of Lidakol in AIDS...